Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Treasury Shares (2016 - 2026)

Pharma-Bio Serv (PBSV) has disclosed Treasury Shares for 11 consecutive years, with $579286.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Treasury Shares rose 5.74% year-over-year to $579286.0, compared with a TTM value of $579286.0 through Oct 2025, up 5.74%, and an annual FY2025 reading of $579286.0, up 5.74% over the prior year.
  • Treasury Shares was $613680.0 for Q4 2025 at Pharma-Bio Serv, up from $599230.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $613680.0 in Q4 2025 and bottomed at $404126.0 in Q1 2021.
  • Average Treasury Shares over 5 years is $520591.0, with a median of $546079.0 recorded in 2023.
  • The sharpest move saw Treasury Shares changed 0.0% in 2021, then rose 26.78% in 2022.
  • Year by year, Treasury Shares stood at $420244.0 in 2021, then increased by 19.51% to $502236.0 in 2022, then grew by 6.84% to $536580.0 in 2023, then grew by 2.1% to $547843.0 in 2024, then rose by 5.74% to $579286.0 in 2025.
  • Business Quant data shows Treasury Shares for PBSV at $579286.0 in Q4 2025, $570084.0 in Q3 2025, and $565080.0 in Q2 2025.